Full View

Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites

M Abbattista, I Martinelli… - Journal of Thrombosis and …, 2021 - Wiley Online Library
Background Real‐world experience with adenoviral vector vaccines against COVID‐19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …
被引用次数：55 相关文章

Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

M Abbattista, I Martinelli, F Peyvandi - JOURNAL OF THROMBOSIS AND …, 2021 - air.unimi.it
Background: Real-world experience with adenoviral vector vaccines against COVID-19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …
[HTML] sciencedirect.com

[HTML][HTML] Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

M Abbattista, I Martinelli, F Peyvandi - Journal of Thrombosis and …, 2021 - Elsevier
Background Real‐world experience with adenoviral vector vaccines against COVID‐19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …
[PDF] portailvasculaire.fr

[PDF][PDF] Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

M Abbattista, I Martinelli, F Peyvandi - 2021 - portailvasculaire.fr
Background: Real-world experience with adenoviral vector vaccines against COVID-19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …

Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites.

M Abbattista, I Martinelli, F Peyvandi - Journal of Thrombosis and …, 2021 - europepmc.org
Background Real-world experience with adenoviral vector vaccines against COVID-19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …
[HTML] nih.gov

[HTML][HTML] Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

M Abbattista, I Martinelli, F Peyvandi - Journal of Thrombosis and …, 2021 - ncbi.nlm.nih.gov
Background Real‐world experience with adenoviral vector vaccines against COVID‐19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …

Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

M Abbattista, I Martinelli… - Journal of thrombosis …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Real-world experience with adenoviral vector vaccines against COVID-19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …

Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

M Abbattista, I Martinelli, F Peyvandi - Journal of Thrombosis and …, 2021 - jthjournal.org
Background Real‐world experience with adenoviral vector vaccines against COVID‐19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …
[PDF] unimi.it

[PDF][PDF] Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

M Abbattista, I Martinelli, F Peyvandi - 2021 - air.unimi.it
Background: Real-world experience with adenoviral vector vaccines against COVID-19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …